Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Sulbactam

A beta-lactamase inhibitor patented in 1977 and in use since 1986 alongside ampicillin: it sacrifices itself by binding the enzymes bacteria use to destroy beta-lactam antibiotics, thus protecting its partner. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Although it was created as a 'shield', it has antibacterial activity of its own against Acinetobacter baumannii: in 2023 it was approved in the United States paired with durlobactam precisely against this bacterium.

SulbactamGo to the active ingredient →
SulbactamActive ingredientSulbactamCat. No. P-S095-001CAS 68373-14-8
Sulbactam-d5Isotopically labelledSulbactam-d5Cat. No. P-S095-012CAS 1322880-00-1

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substanceSulbactam CRSEDQM code Y0000528Family Sulbactam

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.